COVID-19 AstraZeneca vaccine and extremely rare blood clots and translations

AZ vaccine and blood clotting image

This updated factsheet contains important information on the risks and benefits of the COVID-19 AstraZeneca vaccine following reports of a very rare side effect more than 4 days and within 28 days after vaccination. Over the age of 40, the benefits of this vaccine outweigh any potential risk associated with this rare condition. It is important that if you have had one dose of this vaccine with no serious side effects, that you continue to get the second dose with the same vaccine.

COVID-19 AstraZeneca vaccine and extremely rare blood clots is available in BSL and ISL:

A large print accessible version of this leaflet is available below as a Word document. Braille versions of this leaflet are available from Trust vaccination centres or by contacting michelle.mckibben@hscni.net. An audio version of the leaflet is also available.

Details

Format
A4 2 sides
Target group
Adults receiving the COVID-19 AstraZeneca vaccine

Downloads

Attachment Size
COVID-19 AstraZeneca vaccine and extremely rare blood clotting factsheet 534.07 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clotting factsheet - large print accessible version 21.73 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Arabic 0521.pdf 1.25 MB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Bulgarian 0521.pdf 208.38 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Chinese complex 0521.pdf 682.35 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Chinese simplified 0521.pdf 667.65 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Farsi 0521.pdf 284.91 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Hungarian 0521.pdf 200.31 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Irish 0521.pdf 162.65 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Latvian 0521.pdf 502.75 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Lithuanian 0521.pdf 227.77 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Polish 0521.pdf 203.34 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Portuguese 0521.pdf 195.65 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Russian 0521.pdf 518.38 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Slovak 0521.pdf 202.88 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Somali 0521.pdf 167.38 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Tetum 0521.pdf 496.11 KB
COVID-19 AstraZeneca vaccine and extremely rare blood clots Tigrinya 0521.pdf 1.21 MB